PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland.\', \'Division of Infectious Diseases.\', \'Division of Pharmacy Services, Children\'s National Hospital.\', \'Department of Pediatrics, The George Washington University School of Medicine and Health Science, Washington, DC.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/INF.0000000000003263
?:hasPublicationType
?:journal
  • The Pediatric infectious disease journal
is ?:pmid of
?:pmid
?:pmid
  • 34260492
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34260492>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34260492>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all